tallózása szerző szerint "Ramos-Quiroga JA"

A találatok rendezése: Rendezés: Találatok:

  • Konstenius M; Leifman A; van Emmerik-van Oortmerssen K; van de Glind G; Franck J; Moggi F; Ramos-Quiroga JA; Levin FR; Carpentier PJ; Skutle A; Bu E-T; Kaye S; Demetrovics, Zsolt; Barta, Csaba; Auriecomb M; Fatséas M; Johnson B; Faraone SV; Allsop S; Carruthers S; Schoevers RA; Verspreet S; Dom G; Koeter MWJ; van den Brink W (2017)
    Background Childhood trauma exposure (CTE) is frequently reported by those with substance use disorders (SUDs). SUDs also frequently co-occur with attention deficit hyperactivity disorder (ADHD). Objective To investigate ...
  • Franke B; Michelini G; Asherson P; Banaschewski T; Bilbow A; Buitelaar JK; Cormand B; Faraone SV; Ginsberg Y; Haavik J; Kuntsi J; Larsson H; Lesch KP; Ramos-Quiroga JA; Réthelyi, János; Ribases M; Reif A (2018)
    Attention-deficit/hyperactivity disorder (ADHD) is highly heritable and the most common neurodevelopmental disorder in childhood. In recent decades, it has been appreciated that in a substantial number of cases the disorder ...
  • Wapp M; Van De Glind G; Van Emmerik-Van Oortmerssen K; Dom G; Verspreet S; Carpentier PJ; Ramos-Quiroga JA; Skutle A; Bu E-T; Franck J; Konstenius M; Kaye S; Demetrovics Zsolt; Barta Csaba; Fatséas M; Auriacombe M; Johnson B; Faraone SV; Levin FR; Allsop S; Carruthers S; Schoevers RA; Koeter MWJ; Van Den Brink W; Moggi F; IASP Research Group (2015)
  • van de Glind G; Konstenius M; Koeter MWJ; van Emmerik-van Oortmerssen K; Carpentier P-J; Kaye S; Degenhardt L; Skutle A; Franck J; Bu E-T; Moggi F; Dom G; Verspreet S; Demetrovics, Zsolt; Kapitány-Fövény, Máté; Fatséas M; Auriacombe M; Schillinger A; Møller M; Johnson B; Faraone SV; Ramos-Quiroga JA; Casas M; Allsop S; Carruthers S; Schoevers RA; Wallhed S; Barta, Csaba; Alleman P; Levin FR; van den Brink W; IASP Research Group (2014)
    Background: Available studies vary in their estimated prevalence of attention deficit/hyperactivity disorder (ADHD) in substance use disorder (SUD) patients, ranging from 2 to 83%. A better understanding of the possible ...